RAMIREZ, GIUSEPPE ALVISE
 Distribuzione geografica
Continente #
EU - Europa 3.894
AS - Asia 2.646
NA - Nord America 2.352
SA - Sud America 455
AF - Africa 81
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.463
Nazione #
US - Stati Uniti d'America 2.232
RU - Federazione Russa 2.155
SG - Singapore 874
CN - Cina 868
IT - Italia 741
BR - Brasile 373
HK - Hong Kong 274
VN - Vietnam 252
SE - Svezia 233
DE - Germania 176
GB - Regno Unito 142
FR - Francia 130
IN - India 105
CA - Canada 70
FI - Finlandia 66
NL - Olanda 56
TR - Turchia 41
PL - Polonia 38
MX - Messico 37
AU - Australia 33
JP - Giappone 33
AT - Austria 32
ES - Italia 32
ZA - Sudafrica 31
AR - Argentina 30
BD - Bangladesh 30
IQ - Iraq 29
ID - Indonesia 22
EG - Egitto 18
IE - Irlanda 17
IR - Iran 17
LT - Lituania 16
PK - Pakistan 15
BE - Belgio 14
CO - Colombia 13
UA - Ucraina 13
EC - Ecuador 12
SA - Arabia Saudita 11
TN - Tunisia 11
MA - Marocco 9
MY - Malesia 9
PH - Filippine 9
IL - Israele 8
JO - Giordania 8
PY - Paraguay 7
CL - Cile 6
KE - Kenya 6
PT - Portogallo 6
UZ - Uzbekistan 6
VE - Venezuela 6
DO - Repubblica Dominicana 5
TH - Thailandia 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CY - Cipro 4
RO - Romania 4
TW - Taiwan 4
UY - Uruguay 4
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
HR - Croazia 3
BO - Bolivia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
ET - Etiopia 2
GR - Grecia 2
LB - Libano 2
MD - Moldavia 2
NP - Nepal 2
PE - Perù 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BY - Bielorussia 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
FJ - Figi 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LI - Liechtenstein 1
ME - Montenegro 1
MK - Macedonia 1
MM - Myanmar 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
Totale 9.463
Città #
Singapore 490
Moscow 387
Ashburn 354
Dallas 295
Hong Kong 261
San Jose 241
Milan 192
Shanghai 171
Beijing 166
New York 145
Hefei 106
Los Angeles 95
Ho Chi Minh City 94
Lauterbourg 91
Boardman 80
Munich 69
Rome 64
Hanoi 58
Orem 49
Santa Clara 47
Lawrence 42
Princeton 42
Nuremberg 39
São Paulo 36
Chennai 35
Denver 35
Helsinki 35
Warsaw 33
London 32
Tokyo 31
Montreal 28
Atlanta 27
Brooklyn 26
Chicago 25
Ankara 23
Guangzhou 23
Poplar 22
Rio de Janeiro 22
Houston 20
Manchester 19
Bari 18
Genoa 17
Turku 17
Falkenstein 16
Toronto 16
Amsterdam 15
Johannesburg 15
Mexico City 15
Mumbai 15
Seattle 15
Stockholm 15
Washington 15
Da Nang 14
Bologna 13
Boston 13
Council Bluffs 13
Dublin 13
Vienna 13
Belo Horizonte 12
Baghdad 11
Brussels 11
Cape Town 11
Cesano Boscone 11
Frankfurt am Main 11
Lappeenranta 11
Pune 11
Hải Dương 10
Phoenix 10
The Dalles 10
Wollongong 10
Cairo 9
Changsha 9
Secaucus 9
Shenzhen 9
Brisbane 8
Central 8
Istanbul 8
New Delhi 8
Querétaro 8
San Francisco 8
Amman 7
Buffalo 7
Cincinnati 7
Haiphong 7
Melbourne 7
Mugnano di Napoli 7
Paris 7
Sydney 7
Turin 7
Curitiba 6
Hangzhou 6
Jakarta 6
Kyiv 6
Palermo 6
Quezon City 6
St Petersburg 6
Tashkent 6
Topeka 6
Cagliari 5
Campinas 5
Totale 4.658
Nome #
Multidirectional dysfunction of the immune response in patients with systemic lupus erythematosus 356
Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 225
Heart Rate Variability in Subjects with Severe Allergic Background Undergoing COVID-19 Vaccination 203
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 180
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 166
Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study 159
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 151
A novel evidence-based algorithm to predict thromboembolism in patients with COVID-19: preliminary data from a single-centre cohort 149
Biobanking for COVID-19 research 144
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 142
Two-year multidisciplinary follow-up of COVID-19 patients requiring invasive and noninvasive respiratory support 140
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 124
Anifrolumab for Moderate and Severe Muco-Cutaneous Lupus Erythematosus: A Monocentric Experience and Review of the Current Literature 122
Post-traumatic stress disorder in patients with systemic lupus erythematosus heavily affects quality of life. A cross-sectional web survey-based study 120
Beyond Neuropsychiatric Manifestations of Systemic Lupus Erythematosus: Focus on Post-traumatic Stress Disorder and Alexithymia 120
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 118
Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees 117
Continuous positive airway pressure and pronation outside the Intensive Care Unit in COVID-19 acute respiratory distress syndrome 117
Distinctive clinical traits of lupus-related myocarditis: a multicentre retrospective study 115
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 113
LENGTH OF STAY IN INTERNAL MEDICINE: PRELIMINARY DATA FROM A MULTIPURPOSE HOSPITAL REGISTRY 112
Challenges to Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Diseases 108
PTX3 intercepts vascular inflammation in systemic immune-mediated diseases 107
Predictors and outcomes of delirium in the emergency department during the first wave of the COVID-19 pandemic in Milan 107
HOSPITALIZATION COURSE AND OUTCOMES OF CANCER PATIENTS ADMITTED TO INTERNAL MEDICINE UNITS: PRELIMINARY DATA FROM A MULTIPURPOSE HOSPITAL REGISTRY 105
Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19: Thromboembolism, diabetes and COVID-19 104
Influence of reduced muscle mass and quality on ventilator weaning and complications during intensive care unit stay in COVID-19 patients 104
Chromogranin A plasma levels predict mortality in COVID-19 103
Testosterone in males with COVID-19: A twelve-month cohort study 103
COVID-19: Pharmacology and kinetics of viral clearance 103
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 103
Cardiac Safety of mRNA-based Vaccines in Patients with Systemic Lupus Erythematosus and Lupus-like Disorders with a History of Myocarditis 103
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients 103
A continuity care program in chronic, complex and frail patients: the PRO-CCF study protocol 101
Combined plasma levels of IL-10 and testosterone, but not soluble HLA-G5, predict the risk of death in COVID-19 patients 99
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 99
Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency 97
Urgent manifestations of immunoglobulin G4-related disease 96
Catastrophic antiphospholipid syndrome presenting with aortic barrage: case report and review of the literature 93
Severely low testosterone in males with COVID-19: a case-control study 93
Clinical features and outcomes of COVID-19 in patients with IgG4-related disease: A European multi-centre study 89
Choroid plexus and perivascular space enlargement in neuropsychiatric systemic lupus erythematosus 89
Performance of SLE responder index and lupus low disease activity state in real life: A prospective cohort study 89
Choroidal Neovascularization in a Patient with Crohn's Disease 89
A CASE OF PRIMARY ADRENAL EBV+ EXTRANODAL NK/T-CELL LYMPHOMA 88
Is SARS-CoV-2-induced disease a decisive factor influencing testosterone in males? Findings from a case-control ex post facto study 88
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) PRESENTING WITH THYROID DYSFUNCTION: A CASE REPORT 88
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort Study 87
Role of systemic immunosuppression on subglottic stenosis in granulomatosis with polyangiitis: Analysis of a single-centre cohort 86
Chronic glucocorticoid maintenance treatment is associated with the risk of SARS-CoV-2 infection in patients with systemic lupus erythematosus who received vaccination 86
Clinical and dermoscopic features of Castelman's disease: insights from an emblematic case 86
Utility of the “2019 ACR/EULAR classification criteria” for the management of patients with IgG4-related disease 85
Sustainability in Internal Medicine: A Year-Long Ward-Wide Observational Study 85
DIFFERENTIAL PROFILES OF BACTEREMIA IN EMERGENCY AND MEDICINE DEPARTMENTS: PRELIMINARY DATA FROM A MULTIPURPOSE HOSPITAL REGISTRY 84
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort' 83
MACROPHAGE ACTIVATION SYNDROME IN EARLY SYSTEMIC LUPUS ERYTHEMATOSUS: A CLINICAL CASE REPORT 83
Infection-Associated Flares in Systemic Lupus Erythematosus 81
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology 81
Six-month respiratory outcomes and exercise capacity of COVID-19 acute respiratory failure patients treated with continuous positive airway pressure 81
INTRODUCING SUSTAINABILITY IN MEDICINE:THE SIM STUDY 80
INTRODUCING A NOVEL HOSPITAL-TO-HOME CARE PROGRAMME IN CHRONIC/COMPLEX/FRAIL PATIENTS: THE PRO-CCF STUDY 79
PYODERMA GANGRENOSUM REVEALING TAKAYASU ARTERITIS IN A 65-YEAR-OLD CAUCASIAN WOMAN: A CASE REPORT 78
Pharmacological blockade of TNFα prevents sarcopenia and prolongs survival in aging mice 77
Platelet phagocytosis via PSGL1 and accumulation of microparticles in systemic sclerosis 76
EFFICACY AND SAFETY OF CONTINUOUS POSITIVE AIRWAY PRESSURE AND PATIENT MOBILIZATION FOR ARDS DUE TO COVID-19 IN A NON-ICU SETTING 76
PREDICTORS AND OUTCOMES OF DELIRIUM IN THE EMERGENCY DEPARTMENT IN COVID-19 PATIENTS 74
Choroid plexus and perivascular spaces enlargement in neuropsychiatric systemic lupus erythematosus 74
Hypersensitivity reactions to iodinated contrast media in Italy: a retrospective study. Characteristics of patients and risk factors 73
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 73
SECOND AND THIRD LINE ANTIMICROBIAL THERAPY IN INTERNAL MEDICINE DEPARTMENTS: A PROSPECTIVE ANALYSIS ON PRELIMINARY DATA FROM A MULTIPURPOSE HOSPITAL REGISTRY 72
Platelet prothrombotic activity in COVID-19 survivors with persisting respiratory symptoms after 2 years from hospital discharge 72
Neutrophil Extracellular Traps in the Autoimmunity Context 72
Low incidence of intrauterine growth restriction in pregnant patients with systemic lupus erythematosus taking hydroxychloroquine 72
BEHEADED MENINGITIS: A CASE REPORT 70
Selective serotonin reuptake inhibitors and fractures in older nursing home residents: Data from the INCUR study 69
Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year 68
POS0726 POST-TRAUMATIC STRESS DISORDER AND QUALITY OF LIFE IN SYSTEMIC LUPUS ERYTHEMATOSUS. A CROSS SECTIONAL WEB SURVEY-BASED STUDY 68
NONBACTERIAL THROMBOTIC ENDOCARDITIS AND DIFFUSED INTRAVASCULAR COAGULATION IN RAPIDLY PROGRESSING PROSTATIC ADENOCARCINOMA: A CLINICAL CASE 68
WHIPPLE’S BACKLASH: IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME. A CASE REPORT 67
Quantitative MRI adds to neuropsychiatric lupus diagnostics 67
Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19 67
Genome-wide association study of eosinophilic granulomatosis with polyangiitis reveals genomic loci stratified by ANCA status 66
PLASMA AND TISSUE EXPRESSION OF PTX3 IN PATIENTS WITH CHRONIC PERIAORTITIS 66
Testosterone in males with COVID-19: A 7-month cohort study 65
Resting state network functional connectivity abnormalities in systemic lupus erythematosus: correlations with neuropsychiatric impairment 64
DISCORDANT DIAGNOSIS OF PULMONARY LYMPHOMATOID GRANULOMATOSIS AND EBVNEGATIVE DIFFUSE LARGE B-CELL LYMPHOMA IN THE SAME PATIENT, A CASE REPORT 62
COVID-19 in systemic lupus erythematosus: data from a survey on 417 patients 59
MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A SINGLE CENTRE REAL-LIFE EXPERIENCE 58
Efficacy of Siltuximab and 1,927 nm Fractional Laser for the Treatment of Cutaneous Manifestations in Castleman's Disease: The Role of Dermoscopy and Reflectance Confocal Microscopy for Lesion Evaluation 58
Misunderstandings between platelets and neutrophils build in chronic inflammation 58
Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): Prospective study 58
Long-Term Clinical Outcome in Systemic Lupus Erythematosus Patients Followed for More Than 20 Years: The Milan Systemic Lupus Erythematosus Consortium (SMiLE) Cohort 57
Neutrophil extracellular traps profiles in patients with incident systemic lupus erythematosus and lupus nephritis 57
Colchicine treatment in community healthcare setting to prevent severe COVID-19. 54
Evidence for charge-based mimicry in anti dsDNA antibody generation 53
IgG4-related disease and allergen-specific immunotherapy 53
Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): Cross-sectional analysis 53
Neonatal outcomes of children born to mothers on biological agents during pregnancy: State of the art and perspectives 52
Subacute cutaneous Lupus erythematosus induced by dupilumab: a novel possible association with specific pathogenetic mechanisms 50
Serum IgG4 elevation in hyper-inflamed COVID-19 patients. Author's reply 47
Totale 9.434
Categoria #
all - tutte 42.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.122


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214 0 0 0 0 0 0 0 0 0 0 3 1
2021/2022163 3 0 2 22 4 22 9 12 15 9 30 35
2022/2023510 112 93 48 18 25 55 46 53 13 10 19 18
2023/2024708 26 42 72 61 54 142 41 67 15 28 57 103
2024/20251.967 129 67 97 98 151 177 231 211 208 174 153 271
2025/20266.311 517 420 379 805 581 238 588 552 1.912 319 0 0
Totale 9.690